June 12th, 2019 - Allele Enters into Collaboration and Licensing Deal on its cGMP iPSC with Alpine BioTherapeutics for Vision Loss
April 23rd, 2019 - Allele and Addgene Partner to Increase Academic Access to the World’s Brightest Monomeric Fluorescent Protein
April 15th, 2019 - Allele Biotechnology and SCM Lifescience Sign a Joint Research and Development Agreement to Develop iPSC-based Diabetes Treatment
December 4th, 2018 - New iPSC Lines Created for Clinical Development
October 31st, 2018 - Allele Receives iPSC Patents Bolstering Current Production of Multiple Lines at Wholly Owned cGMP Facility
January 6th, 2017 - Allele Biotechnology to Develop iPSC-Derived Cell Therapies with Focus on Diabetes and Spinal Cord Injury